Hiromichi Yoshizawa

Characteristics of urinary and serum soluble Klotho protein in patients with different degrees of chronic kidney disease

Tetsu Akimoto, Hiromichi Yoshizawa, Yuko Watanabe et al. · BMC Nephrology · 2012 · 119 citations · Full text

Delivery of microRNA-146a with polyethylenimine nanoparticles inhibits renal fibrosis in vivo

Yoshiyuki Morishita, Toshimi Imai, Hiromichi Yoshizawa et al. · International Journal of Nanomedicine · 2015 · 107 citations · Full text

Nanoparticles, Engineering, Renal Pathology +21

Promoter methylation confers kidney‐specific expression of the <i>Klotho</i> gene

Masahiro Azuma, Daisuke Koyama, Jiro Kikuchi et al. · The FASEB Journal · 2012 · 82 citations · Full text

Suppressor Geneklotho, Epigenetic Change, Genetics +22

Effects of the sodium‐glucose cotransporter 2 inhibitor dapagliflozin on fluid distribution: A comparison study with furosemide and tolvaptan

Ken Ohara, Takahiro Masuda, Takuya Murakami et al. · Nephrology · 2018 · 78 citations

siRNAs targeted to Smad4 prevent renal fibrosis in vivo

Yoshiyuki Morishita, Hiromichi Yoshizawa, Minami Watanabe et al. · Scientific Reports · 2014 · 44 citations · Full text

Antifibrotic Therapy, Renal Pathology, Immunology +19